Cat. No.: X23-10-ZQ394
JAK inhibitor JANEX-1, Purity ≥98%
Synonym: JANEX-1; 202475-60-3; WHI-P131; jak3 inhibitor i; Janex 1; 4-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenol; 4-(6,7-dimethoxyquinazolin-4-ylamino)phenol; JAK inhibitor
- MDL: MFCD01862614
- CAS Number: 202475-60-3
- Compound CID: 3794
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
JANEX-1, soluble in DMSO and insoluble in ethanol and water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK3.
Molecular Formula
C16H15N3O3
Solubility
DMSO: 5 mg/mL (16.81 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
JANEX-1 can be used to investigate inhibition of JAK3 and its related signaling pathways.
Related Products
-
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
-
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
-
JAK inhibitor Abrocitinib, Purity ≥98%
-
JAK inhibitor AZ-3, Purity ≥98%
-
JAK inhibitor AZ-960, Purity ≥98%
-
JAK inhibitor AZD1480, Purity ≥98%
Quick Links